With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on AstraZeneca's influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17.
GlobalData on MSN4d
FDA approves AstraZeneca FluMist ‘flu vaccine for self-administrationSince its initial US approval in 2003, 200 million doses of FluMist have been distributed globally. The new ...
And on 20 September, the US FDA approved AstraZeneca’s FluMist influenza nasal spray vaccine for self-administration.
AstraZeneca says FluMist has been shown to be as effective as other flu vaccines.When the FDA announced last year that it was reviewing the possibility of a self-administered flu vaccine ...
FluMist won't be available until next year, according to the website for FluMist, which is owned by AstraZeneca. Once ...
AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback